Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114958) titled 'Effect analysis and mechanism study of Abrocitinib in the treatment of bullous pemphigoid' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Peking University First Hospital
Condition:
Bullous pemphigoid
Intervention:
Control group:Corticosteroid combined with minocycline
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-04-18
Target Sample Size: Control group:15;Experimental group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=286974
Published by HT Digital Con...